about
Novel bile acid therapeutics for the treatment of chronic liver diseasesMolecular changes in hepatic metabolism and transport in cirrhosis and their functional importancePharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of CholestasisProposed therapies in primary biliary cholangitis.Obeticholic acid for the treatment of primary biliary cirrhosis.Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate.Emerging pharmacologic therapies for primary sclerosing cholangitis.Management of cholestatic disease in 2017.New therapeutic concepts in bile acid transport and signaling for management of cholestasis.Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.Old and new treatments for primary biliary cholangitis.The emerging role of mast cells in liver disease.Mechanisms of bile acid mediated inflammation in the liver.Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.PPARα activation protects against cholestatic liver injury.From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.Bile acid metabolism in liver pathobiology.Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.Schisandrol B protects against cholestatic liver injury through pregnane X receptors.The Interaction of PPARα and CYP7B1 with ERα, β Impacted the Occurrence and Development of Intrahepatic Cholestasis in Pregnant Rats.The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.Update on pharmacotherapies for cholestatic liver disease.Thyroid hormone receptor β1 stimulates to increase biliary phosphatidylcholine excretion in miceβ-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids Farnesoid X Receptor and Constitutive Androstane ReceptorBile acid metabolism and signaling in liver disease and therapyIdentification of a xenobiotic as a potential environmental trigger in primary biliary cholangitisIdentification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses
P2860
Q26748613-AA68DD45-B88D-49C3-9CF2-2CD2B3F75B60Q26769609-829DB78C-1475-45A5-BDDC-5D7200A64C53Q36464051-83C0D1E5-965F-4844-980E-C01969FE12B7Q36748184-8F5957F6-3712-410F-BC85-2F13DF62327DQ37072380-26B3215C-1251-4E6A-B49C-E94DD3D8470CQ38628470-67AFDE72-8441-40D9-A37B-458F763E2B6FQ38711012-4DC25889-10F0-4B91-AD1B-1DFBB930EFCAQ38751076-28FA6B84-2CEE-4D36-8BDE-FCE6C05F15B4Q38774857-55359705-66A5-48AE-B8D2-33BF92DD4F18Q39044702-D792237D-9008-47CC-B453-8F2CA2299922Q39047912-0E767D6C-4027-4AF8-B3D3-007AE378EFCCQ39216355-15A88D6B-D56D-4B0F-B0E0-AABE4D3644CDQ39284642-55BFF463-3754-44BA-B900-8AD4C2A5194DQ39367594-9944663D-E09B-4046-BD9C-41845B5CE284Q39584105-E455FB72-856B-4A10-B653-8FA8BE9A2B0BQ41565916-E82F62C6-1E78-4973-A40F-3614095C6D77Q46135644-5AD59DBB-472E-4256-8360-C2190067C365Q46522249-F08016C5-1848-4E33-99A3-8FA240F8C4ECQ47572843-42936E83-F94D-4386-BD6E-CDD0F17913F4Q47615113-6A6A71BD-7B8D-4B9C-9249-4E18301BBF52Q47645986-99EE0C7B-381E-49CD-8B3D-1448D4A7A948Q49650135-96037992-0952-4020-B6BB-9A2FA0F53CF6Q51166136-F5505DBE-A579-4EF4-990E-37EEAE6EC49FQ51506875-33C7BE65-FEEC-41EE-B487-2C021892770DQ52624982-16C91BC9-04B9-4B16-A24A-11AF1C5DE8FBQ55333522-38EA0E16-C678-4DD8-9310-BA97B744B59CQ57109925-66192990-C15B-437B-9DCB-EB482F5728A8Q57113962-6DBE7048-CE1F-4945-819A-E6C75EB76030Q57128767-DD6C6C70-5683-4911-8AC8-12B22FDC7256Q58702534-DA04D294-E69D-4AFE-8DF6-59C545635B7BQ58762274-09A04DE5-49A6-449A-A242-ADE334E7FAE5
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fibrates and cholestasis
@ast
Fibrates and cholestasis
@en
type
label
Fibrates and cholestasis
@ast
Fibrates and cholestasis
@en
prefLabel
Fibrates and cholestasis
@ast
Fibrates and cholestasis
@en
P2093
P2860
P356
P1433
P1476
Fibrates and cholestasis
@en
P2093
David N Assis
James L Boyer
Nisanne S Ghonem
P2860
P304
P356
10.1002/HEP.27744
P407
P577
2015-03-23T00:00:00Z